Skip to main content
OpenTrials
Completed

NCT Number: NCT07489183

A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older

A prospective, open, observational study to confirm the lipid-lowering effect, changes in glucose metabolism, and safety after 6 months of administration of atostazet to hypercholesterolemic patients 65 years of age or older

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypercholesterolemia Dyslipidemias Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Building 1897

Seoul, 04516, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males or females aged ≥ 65 years
  • Primary Hypercholesterolemia
  • moderate risk or higher patient based on Korean Guidelines for the Management of Dyslipidemia (the 4th edition)

Exclusion criteria

  • Patients with a known hypersensitivity to any of the major or minor components of the study drug
  • Patients with active hepatic disease or unexplained persistently elevated serum aminotransferase levels
  • Patients with myopathies
  • Patients receiving glecaprevir and pibrentasvir

Treatment and study plan

Primary outcomes

  1. Incidence of Adverse events

    Time frame: 24 weeks to the base

    Incidence of Adverse events

Sponsors and collaborators

Lead sponsor

Dong Wha Pharmaceutical Co. Ltd.

Industry

Registry information

Acronym: DW-EAZ-OS01

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Mar 24, 2026
Registry last updated
Mar 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.